Skip to main content

Table 4 Intraoperative and postoperative characteristics in patients with EuroSCORE II ≥ 4.15

From: The impact of glutamate infusion on postoperative NT-proBNP in patients undergoing coronary artery bypass surgery: a randomized study

VariablesEuroSCOREII ≥ 4.15
(n = 101)
Glutamate
(n = 56)
Control
(n = 45)
p-value
Aortic crossclamp time (min)53 [42–67]54 [41–65]52 [42–67]0.91
CPB time (min)80 [65–106]81 [64–104]79 [67–107]0.74
Reperfusion time (min)23 [16–30]24 [17–30]21 [16–29]0.53
NT-proBNP POD1 (ng•L−1)4170 [2850–6185]3786 [2630–5380]4675 [3010–6650]0.21
NT-proBNP POD3 (ng•L−1)6650 [3800–9970]4845 [3426–7423]8430 [5370–14,100]0.001
Delta NT-proBNP POD1-Pre (ng•L−1)2800 [1650–4760]2653 [1540–3675]3050 [2030–5560]0.13
Delta NT-proBNP POD3-Pre (ng•L−1)5210 [3115–8595]3900 [2995–6260]6745 [3455–12,687]0.012
CK-MB POD1 (µg•L−1)18 [11–25]14 [9–23]19 [12–26]0.12
TroponinT POD3 (ng•L−1)390 [190–730]290 [160–480]550 [210–860]0.015
Delta Troponin T POD3-Pre (ng•L−1)270 [135–600]270 [130–450]350 [150–680]0.44
Inotropic support43% (43)43% (24)42% (19)1.00
ICU stay (h)22 [19–42]21 [19–26]25 [22–45]0.022
ICU stay > 72 h18% (18)16% (9)20% (9)0.61
Ventilation time (h)5 [3–12]4 [3–9]5 [3–20]0.3
Ventilation time > 48 h11% (11)11% (6)11% (5)1
PHF22% (22)15% (8)31% (14)0.053
Severe PHF9% (9)4% (2)16% (7)0.074
Postoperative stroke4% (3)4% (2)4% (2)1
AKI29% (29)25% (14)33% (15)0.51
Hospital Mortality5% (5)4% (2)7% (3)0.65
  1. Data given as medians [interquartile range] or percentages (number)
  2. AKI acute kidney injury, CK-MB creatine kinase-MB isoenzyme, CPB cardiopulmonary bypass, ICU intensive care unit, PHF postoperative heart failure, POD postoperative day